Michael J. Farrell net worth and biography

Michael Farrell Biography and Net Worth

CEO of ResMed
Michael “Mick” Farrell was appointed ResMed’s CEO and has served as a director since March 2013. He joined the company in 2000, serving as president of the Americas region from 2011 to 2013, senior vice president of the global sleep apnea business unit from 2007 to 2011, and various senior roles in marketing and business development.

Before joining ResMed, Mick worked in management consulting, biotechnology, chemicals and metals manufacturing at companies including Arthur D. Little, Sanofi Genzyme, Dow Chemical, and BHP.

Mick serves on the board of directors of ResMed, the Advanced Medical Technology Association (AdvaMed) and Zimmer Biomet (NYSE: ZBH), a multibillion dollar public company that provides implantable musculoskeletal medical devices for patients globally. He is also a member of two committees at Zimmer Biomet: the compensation and management development committee, as well as the quality, regulatory & technology committee, where he also serves as Chair. Mick also volunteers as a trustee for non-profit organizations: UC San Diego Foundation, Rady Children’s Hospital, and Father Joe’s Villages’ project for the homeless in San Diego, California.

Mick holds a bachelor of engineering with first-class honors from the University of New South Wales, a Master of Science in chemical engineering from the Massachusetts Institute of Technology, and a Master of Business Administration from the MIT Sloan School of Management.

What is Michael J. Farrell's net worth?

The estimated net worth of Michael J. Farrell is at least $90.82 million as of November 15th, 2022. Mr. Farrell owns 414,024 shares of ResMed stock worth more than $90,816,164 as of December 6th. This net worth evaluation does not reflect any other assets that Mr. Farrell may own. Additionally, Mr. Farrell receives an annual salary of $2,660,000.00 as CEO at ResMed. Learn More about Michael J. Farrell's net worth.

How old is Michael J. Farrell?

Mr. Farrell is currently 50 years old. There are 4 older executives and no younger executives at ResMed. Learn More on Michael J. Farrell's age.

What is Michael J. Farrell's salary?

As the CEO of ResMed Inc., Mr. Farrell earned a total compensation package of $10,389,315.00 in 2021. Mr. Farrell earned a salary of $1,050,000.00, stock awards of $7,700,000.00, non-equity compensation of $1,603,000.00, and other compensation of $36,315.00. Learn More on Michael J. Farrell's salary.

How do I contact Michael J. Farrell?

The corporate mailing address for Mr. Farrell and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected] Learn More on Michael J. Farrell's contact information.

Has Michael J. Farrell been buying or selling shares of ResMed?

In the last ninety days, Michael J. Farrell has sold $3,570,223.90 in ResMed stock. Most recently, Michael J. Farrell sold 5,675 shares of the business's stock in a transaction on Tuesday, November 15th. The shares were sold at an average price of $224.64, for a transaction totalling $1,274,832.00. Following the completion of the sale, the chief executive officer now directly owns 414,024 shares of the company's stock, valued at $93,006,351.36. Learn More on Michael J. Farrell's trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Robert Douglas (COO), Michael Farrell (CEO), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 38 times. They sold a total of 184,983 shares worth more than $42,564,363.27. The most recent insider tranaction occured on November, 22nd when insider Justin Leong sold 3,777 shares worth more than $866,821.50. Insiders at ResMed own 1.4 % of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 11/22/2022.

Michael J. Farrell Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/15/2022Sell5,675$224.64$1,274,832.00414,024View SEC Filing Icon  
11/10/2022Sell4,880$220.83$1,077,650.40422,654View SEC Filing Icon  
10/17/2022Sell5,675$214.58$1,217,741.50422,570View SEC Filing Icon  
9/15/2022Sell5,675$228.96$1,299,348.00422,570View SEC Filing Icon  
7/15/2022Sell5,675$224.94$1,276,534.50405,260View SEC Filing Icon  
6/15/2022Sell5,675$202.54$1,149,414.50405,260View SEC Filing Icon  
5/16/2022Sell5,675$196.61$1,115,761.75405,260View SEC Filing Icon  
4/18/2022Sell5,675$232.41$1,318,926.75405,229View SEC Filing Icon  
3/15/2022Sell5,675$242.37$1,375,449.75View SEC Filing Icon  
2/15/2022Sell5,675$234.06$1,328,290.50View SEC Filing Icon  
1/18/2022Sell5,675$241.94$1,373,009.50View SEC Filing Icon  
12/15/2021Sell5,675$255.53$1,450,132.75View SEC Filing Icon  
2/10/2020Sell6,647$172.21$1,144,679.87361,347View SEC Filing Icon  
1/13/2020Sell6,651$157.43$1,047,066.93361,351View SEC Filing Icon  
11/26/2019Sell1,370$149.26$204,486.20354,700View SEC Filing Icon  
11/11/2019Sell6,651$143.94$957,344.94View SEC Filing Icon  
10/14/2019Sell6,651$129.83$863,499.33310,975View SEC Filing Icon  
9/9/2019Sell6,651$137.38$913,714.38310,975View SEC Filing Icon  
8/12/2019Sell6,651$132.35$880,259.85292,988View SEC Filing Icon  
7/8/2019Sell6,651$123.76$823,127.76292,988View SEC Filing Icon  
6/10/2019Sell6,651$118.16$785,882.16292,988View SEC Filing Icon  
5/13/2019Sell6,651$109.72$729,747.72View SEC Filing Icon  
4/8/2019Sell6,651$100.82$670,553.82292,933View SEC Filing Icon  
3/11/2019Sell6,651$101.05$672,083.55292,933View SEC Filing Icon  
2/11/2019Sell6,651$97.18$646,344.18288,799View SEC Filing Icon  
1/14/2019Sell6,651$113.75$756,551.25292,933View SEC Filing Icon  
11/16/2018Sell3,300$104.49$344,817.00240,487View SEC Filing Icon  
10/17/2016Sell5,975$64.25$383,893.75203,781View SEC Filing Icon  
9/15/2016Sell5,975$64.84$387,419.00View SEC Filing Icon  
8/15/2016Sell5,975$70.41$420,699.75View SEC Filing Icon  
7/15/2016Sell5,975$65.03$388,554.25154,814View SEC Filing Icon  
6/15/2016Sell5,975$59.63$356,289.25154,814View SEC Filing Icon  
5/16/2016Sell5,975$57.64$344,399.00154,723View SEC Filing Icon  
4/15/2016Sell5,975$59.34$354,556.50154,723View SEC Filing Icon  
3/15/2016Sell5,975$58.57$349,955.75150,852View SEC Filing Icon  
2/16/2016Sell5,975$58.20$347,745.00144,878View SEC Filing Icon  
1/15/2016Sell5,975$53.07$317,093.25144,878View SEC Filing Icon  
11/16/2015Sell5,975$57.03$340,754.25144,878View SEC Filing Icon  
10/15/2015Sell5,975$55.35$330,716.25172,370View SEC Filing Icon  
9/15/2015Sell5,975$50.89$304,067.75172,370View SEC Filing Icon  
8/17/2015Sell5,975$55.54$331,851.50View SEC Filing Icon  
7/15/2015Sell5,975$57.59$344,100.25View SEC Filing Icon  
6/15/2015Sell5,975$57.87$345,773.25View SEC Filing Icon  
3/16/2015Sell5,975$69.10$412,872.50View SEC Filing Icon  
9/15/2014Sell3,200$52.41$167,712.00View SEC Filing Icon  
7/15/2014Sell3,200$49.22$157,504.00View SEC Filing Icon  
6/16/2014Sell3,200$53.20$170,240.00View SEC Filing Icon  
8/8/2012Sell30,000$35.58$1,067,400.00View SEC Filing Icon  
See Full Table

Michael J. Farrell Buying and Selling Activity at ResMed

This chart shows Michael J Farrell's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $217.69
Low: $215.87
High: $226.99

50 Day Range

MA: $221.81
Low: $208.94
High: $233.97

2 Week Range

Now: $217.69
Low: $189.40
High: $268.77

Volume

25,037 shs

Average Volume

409,826 shs

Market Capitalization

$31.89 billion

P/E Ratio

40.69

Dividend Yield

0.76%

Beta

0.47
Potential Gold Rush For Investors Sparked By USA Vs. China Trade War
Right now, China has the US Military in a stranglehold. They hold a monopoly on one of our most CRITICAL defense elements. But thanks to executive orders from both Biden and Trump...
China's Monopoly Is About To Crumble...